(PDF, 59.81 KB)
Published, December 17th 2013
The Health Council of the Netherlands advises the Minister of Health, Welfare and Sport to grant a permit for a pilot introduction of NIPT, a new type of test which can be used to detect in the pregnant woman’s blood whether a fetus is affected by a serious congenital disorder, such as Down’s syndrome. The test will become available for women who are at a relatively high risk of carrying a fetus with Down’s syndrome. This approach means that fewer women have to undergo chorionic villus sampling or amniocentesis. For the moment, NIPT will be an additional test, after the so called combined test.
This is indicated in the advisory report Population Screening Act: noninvasive prenatal test for increased risk of trisomy, which has been published today. In this report the Health Council advises about granting the permit at the request of the Minister of Health, Welfare and Sport. At the same time a horizon scanning report has been published, in which the Council discusses NIPT from an ethical perspective and in the context of general developments in prenatal screening.
This publication may be cited as follows
Health Council of the Netherlands. Population Screening Act: noninvasive prenatal test for increased risk of trisomy. The Hague: Health Council of the Netherlands, 2013; publication no. 2013/35. ISBN 978-90-5549-984-7